Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
08/11/2023 | KOEMPEL MICHAEL | CFO | Purchase | Common Stock | 1.8k | $8.34 | $14.7k | | 08/10/2023 |
08/10/2023 | KOEMPEL MICHAEL | CFO | Purchase | Common Stock | 3.2k | $8.41 | $27.2k | | 08/10/2023 |
05/22/2023 | Mellini Paul V | Director | Exercise | NQ Stock Options | 1000 | $7.95 | $8k | | 05/22/2023 |
05/18/2023 | BENSTOCK MICHAEL | CEO | Purchase | Common Stock | 9.7k | $8.80 | $85k | | 05/17/2023 |
05/17/2023 | BENSTOCK MICHAEL | CEO | Purchase | Common Stock | 5.6k | $8.62 | $48.4k | | 05/17/2023 |
05/16/2023 | BENSTOCK MICHAEL | CEO | Purchase | Common Stock | 3.3k | $8.82 | $29.4k | | 05/15/2023 |
05/15/2023 | BENSTOCK MICHAEL | CEO | Purchase | Common Stock | 2.4k | $8.41 | $19.9k | | 05/15/2023 |
05/12/2023 | BENSTOCK MICHAEL | CEO | Purchase | Common Stock | 1.3k | $8.19 | $10.6k | | 05/11/2023 |
05/12/2023 | Mellini Paul V | Director | Grant | NQ Stock Options | 2.8k | $8.33 | $22.9k | | 05/12/2023 |
05/12/2023 | HENSLEY ROBIN | Director | Grant | NQ Stock Options | 2.8k | $8.33 | $22.9k | | 05/12/2023 |
05/12/2023 | Fields Venita Elaine | Director | Grant | NQ Stock Options | 2.8k | $8.33 | $22.9k | | 05/12/2023 |
05/12/2023 | SIEGEL TODD E | Director | Grant | NQ Stock Options | 2.8k | $8.33 | $22.9k | | 05/12/2023 |
05/12/2023 | DEMOTT ANDREW D JR | Director | Grant | NQ Stock Options | 2.8k | $8.33 | $22.9k | | 05/12/2023 |
05/11/2023 | BENSTOCK MICHAEL | CEO | Purchase | Common Stock | 731 | $7.99 | $5.8k | | 05/11/2023 |
02/21/2023 | Fields Venita Elaine | Director | Gift | Common Stock | 3k | $0.00 | $0 | | 02/21/2023 |
02/03/2023 | HIMELSTEIN JAKE | President, BAMKO, LLC | Grant | Stock Options (Right to Buy) | 8.3k | $12.04 | $100k | | 02/03/2023 |
02/03/2023 | HIMELSTEIN JAKE | President, BAMKO, LLC | Grant | Stock Appreciation Rights | 1.7k | $12.04 | $20.4k | | 02/03/2023 |
02/03/2023 | DONLAN CATHERINE BELDOTTI | President, SUG Healthcare | Grant | Stock Options (Right to Buy) | 5.8k | $12.04 | $70k | | 02/03/2023 |
02/03/2023 | DONLAN CATHERINE BELDOTTI | President, SUG Healthcare | Grant | Stock Appreciation Rights | 489 | $12.04 | $5.9k | | 02/03/2023 |
02/03/2023 | KOEMPEL MICHAEL | CFO | Grant | Common Stock | 20.6k | $0.00 | $0 | | 02/03/2023 |
02/03/2023 | KOEMPEL MICHAEL | CFO | Grant | Stock Options (Right to Buy) | 6.1k | $12.04 | $73k | | 02/03/2023 |
02/03/2023 | KOEMPEL MICHAEL | CFO | Grant | Stock Appreciation Rights | 13.9k | $12.04 | $167.8k | | 02/03/2023 |
02/03/2023 | Leide Dominic | President, The Office Gurus | Grant | Stock Appreciation Rights | 1.7k | $12.04 | $20.4k | | 02/03/2023 |
02/03/2023 | Leide Dominic | President, The Office Gurus | Grant | Stock Options (Right to Buy) | 8.3k | $12.04 | $100k | | 02/03/2023 |
02/03/2023 | Koosed Philip | Chief Strategy Officer | Grant | Stock Options (Right to Buy) | 8.3k | $12.04 | $100k | | 02/03/2023 |
02/03/2023 | Koosed Philip | Chief Strategy Officer | Grant | Stock Appreciation Rights | 11.7k | $12.04 | $140.8k | | 02/03/2023 |
02/03/2023 | Alpert Jordan M. | Sr VP General Counsel & Secy | Grant | Stock Options (Right to Buy) | 6k | $12.04 | $72.2k | | 02/03/2023 |
02/03/2023 | BENSTOCK MICHAEL | CEO | Grant | Common Stock | 96.4k | $0.00 | $0 | | 02/03/2023 |
02/03/2023 | BENSTOCK MICHAEL | CEO | Grant | Stock Options (Right to Buy) | 8.3k | $12.04 | $100k | | 02/03/2023 |
02/03/2023 | BENSTOCK MICHAEL | CEO | Grant | Stock Appreciation Rights | 21.7k | $12.04 | $261.2k | | 02/03/2023 |
01/01/2023 | DONLAN CATHERINE BELDOTTI | President, SUG Healthcare | Grant | Performance Share Award | 88k | $0.00 | $0 | | 01/01/2023 |
12/02/2022 | DONLAN CATHERINE BELDOTTI | President, SUG Healthcare | Grant | Stock Options (Right to Buy) | 3k | $9.95 | $30k | | 12/02/2022 |
12/02/2022 | HIMELSTEIN JAKE | President, BAMKO, LLC | Grant | Stock Appreciation Rights | 2.8k | $9.95 | $28.3k | | 12/02/2022 |
12/02/2022 | KOEMPEL MICHAEL | CFO | Grant | Stock Options (Right to Buy) | 2.7k | $9.95 | $27k | | 12/02/2022 |
12/02/2022 | Koosed Philip | Chief Strategy Officer | Grant | Stock Appreciation Rights | 4.3k | $9.95 | $42.4k | | 12/02/2022 |
|